First-year radiographic progression as a predictor of further progression in early arthritis: Results of a large national French cohort

Arthritis Care and Research

Volumn 65, Issue 12, 2013, Pages 1907-1915

  Tobón, Gabriel ^a   Saraux, Alain ^a   Lukas, Cedric ^b   Gandjbakhch, Frederique ^c   Gottenberg, J E ^d   Mariette, Xavier ^e   Combe, Bernard ^b   Devauchelle Pensec, Valerie ^a  

^a CHU MORVAN   (France)

^b LAPEYRONIE HOSPITAL   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^e UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTHRITIS; ARTICLE; CONCENTRATION (PARAMETERS); DAS28; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE DURATION; EARLY ARTHRITIS; EROSION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOOT RADIOGRAPHY; HAND RADIOGRAPHY; HUMAN; JOINT CAVITY; JOINT DESTRUCTION; MAJOR CLINICAL STUDY; MALE; MODIFIED SHARP SCORE; MORNING STIFFNESS; OPERATION DURATION; PREDICTION; PROSPECTIVE STUDY; RADIOGRAPHY; RECEIVER OPERATING CHARACTERISTIC; RHEUMATOID NODULE; SCORING SYSTEM;

ARTHRITIS, RHEUMATOID; ARTHROGRAPHY; COHORT STUDIES; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED;

EID: 84889003313     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22078     Document Type: Article

References (42)

1. Boonen A, van der Heijde D,. Conventional x-ray in early arthritis. Rheum Dis Clin North Am 2005; 31: 681-98.
2. Sharp JT, Wolfe F, Mitchell DM, Bloch DA,. The progression of erosion and joint space narrowing scores in rheumatoid arthritis during the first twenty-five years of disease. Arthritis Rheum 1991; 34: 660-8.
3. Van der Heijde DM, van Leeuwen MA, van Riel PL, Koster AM, van 't Hof MA, van Rijswijk MH, et al. Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis. Arthritis Rheum 1992; 35: 26-34.
4. Hulsmans HM, Jacobs JW, van der Heijde DM, van Albada-Kuipers GA, Schenk Y, Bijlsma JW,. The course of radiologic damage during the first six years of rheumatoid arthritis. Arthritis Rheum 2000; 43: 1927-40.
5. Wolfe F, Albert DA, Pincus T,. A survey of United States rheumatologists concerning effectiveness of disease-modifying antirheumatic drugs and prednisone in the treatment of rheumatoid arthritis. Arthritis Care Res 1998; 11: 375-81.
6. Boini S, Guillemin F,. Radiographic scoring methods as outcome measures in rheumatoid arthritis: properties and advantages. Ann Rheum Dis 2001; 60: 817-27.
7. Genant HK, Jiang Y, Peterfy C, Lu Y, Redei J, Countryman PJ,. Assessment of rheumatoid arthritis using a modified scoring method on digitized and original radiographs. Arthritis Rheum 1998; 41: 1583-90.
8. Van der Heijde DM,. Radiographic imaging: the 'gold standard' for assessment of disease progression in rheumatoid arthritis. Rheumatology (Oxford) 2000; 39 Suppl 1: 9-16.
9. Combe B, Benessiano J, Berenbaum F, Cantagrel A, Daures JP, Dougados M, et al. The ESPOIR cohort: a ten-year follow-up of early arthritis in France. Methodology and baseline characteristics of the 813 included patients. Joint Bone Spine 2007; 74: 440-5.
10. Gaujoux-Viala C, Paternotte S, Combe B, Dougados M,. Evidence of the symptomatic and structural efficacy of methotrexate in daily practice as the first disease-modifying drug in rheumatoid arthritis despite its suboptimal use: results from the ESPOIR early synovitis cohort. Rheumatology (Oxford) 2012; 51: 1648-54.
11. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
12. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62: 2569-81.
13. Devauchelle-Pensec V, Josseaume T, Samjee I, Dougados M, Combe B, Saraux A,. Ability of oblique foot radiographs to detect erosions in early arthritis: results in the ESPOIR cohort. Arthritis Rheum 2008; 59: 1729-34.
14. Gottenberg JE, Dayer JM, Lukas C, Ducot B, Chiocchia G, Cantagrel A, et al. Serum IL-6 and IL-21 are associated with markers of B cell activation and structural progression in early rheumatoid arthritis: results from the ESPOIR cohort. Ann Rheum Dis 2012; 71: 1243-8.
15. Bland JM, Altman DG,. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-10.
16. Bruynesteyn K, Boers M, Kostense P, van der Linden S, van der Heijde D,. Deciding on progression of joint damage in paired films of individual patients: smallest detectable difference or change. Ann Rheum Dis 2005; 64: 179-82.
17. Sharp JT, Young DY, Bluhm GB, Brook A, Brower AC, Corbett M, et al. How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? Arthritis Rheum 1985; 28: 1326-35.
18. Van der Heijde DM, van Riel PL, Nuver-Zwart IH, Gribnau FW, vad de Putte LB,. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet 1989; 1: 1036-8.
19. Metz CE,. Basic principles of ROC analysis. Semin Nucl Med 1978; 8: 283-98.
20. Funovits J, Aletaha D, Bykerk V, Combe B, Dougados M, Emery P, et al. The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: methodological report phase I. Ann Rheum Dis 2010; 69: 1589-95.
21. Visser K, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Ronday HK, Seys PE, Kerstens PJ, et al. A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study. Ann Rheum Dis 2010; 69: 1333-7.
22. Rezaei H, Saevarsdottir S, Forslind K, Albertsson K, Wallin H, Bratt J, et al. In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial. Ann Rheum Dis 2012; 71: 186-91.
23. Devauchelle-Pensec V, Saraux A, Berthelot JM, Alapetite S, Chales G, Le Henaff C, et al. Ability of hand radiographs to predict a further diagnosis of rheumatoid arthritis in patients with early arthritis. J Rheumatol 2001; 28: 2603-7.
24. Okubo S, Lehtinen K, Isomaki H,. Sensitivity of radiographic changes of hand and foot joints as a diagnostic criterion in patients with rheumatoid arthritis. Scand J Rheumatol 1992; 21: 145-7.
25. Larsen A, Dale K, Eek M,. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn (Stockh) 1977; 18: 481-91.
26. Lukas C, Landewe R, Fatenejad S, van der Heijde D,. Subtle changes in individual joints result in both positive and negative change scores in a patient: results from a clinical trial in patients with rheumatoid arthritis. Ann Rheum Dis 2009; 68: 1691-5.
27. Yazici Y, Sokka T, Pincus T,. Radiographic measures to assess patients with rheumatoid arthritis: advantages and limitations. Rheum Dis Clin North Am 2009; 35: 723-9.
28. Neumann G, dePablo P, Finckh A, Chibnik LB, Wolfe F, Duryea J,. Patient repositioning reproducibility of joint space width measurements on hand radiographs. Arthritis Care Res (Hoboken) 2011; 63: 203-7.
29. Bukhari M, Lunt M, Harrison BJ, Scott DG, Symmons DP, Silman AJ,. Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis: results from the Norfolk Arthritis Register Study, a large inception cohort. Arthritis Rheum 2002; 46: 906-12.
30. Jansen LM, van Schaardenburg D, van der Horst-Bruinsma IE, Dijkmans BA,. One year outcome of undifferentiated polyarthritis. Ann Rheum Dis 2002; 61: 700-3.
31. Visser H, le Cessie S, Vos K, Breedveld FC, Hazes JM,. How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum 2002; 46: 357-65.
32. Scire CA, Verstappen SM, Mirjafari H, Bunn DK, Lunt M, Montecucco C, et al. Reduction of long-term disability in inflammatory polyarthritis by early and persistent suppression of joint inflammation: results from the Norfolk Arthritis Register. Arthritis Care Res (Hoboken) 2011; 63: 945-52.
33. Gossec L, Paternotte S, Aanerud GJ, Balanescu A, Boumpas DT, Carmona L, et al. Finalisation and validation of the Rheumatoid Arthritis Impact of Disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative. Ann Rheum Dis 2011; 70: 935-42.
34. Dougados M,. Can we combine patient's and doctor's perspective when assessing rheumatoid arthritis disease activity? J Rheumatol 2007; 34: 1949-52.
35. Smolen JS, van der Heijde DM, Keystone EC, van Vollenhoven RF, Goldring MB, Guerette B, et al. Association of joint space narrowing with impairment of physical function and work ability in patients with early rheumatoid arthritis: protection beyond disease control by adalimumab plus methotrexate. Ann Rheum Dis 2013; 72: 1156-62.
36. Fautrel B, Granger B, Combe B, Saraux A, Guillemin F, Le Loet X,. Matrix to predict rapid radiographic progression of early rheumatoid arthritis patients from the community treated with methotrexate or leflunomide: results from the ESPOIR cohort. Arthritis Res Ther 2012; 14: R249.
37. Boissier MC,. Cell and cytokine imbalances in rheumatoid synovitis. Joint Bone Spine 2008; 78: 230-4.
38. Li H, Hong S, Qian J, Zheng Y, Yang J, Yi Q,. Cross talk between the bone and immune systems: osteoclasts function as antigen-presenting cells and activate CD4+ and CD8+ T cells. Blood 2010; 116: 210-7.
39. Axmann R, Bohm C, Kronke G, Zwerina J, Smolen J, Schett G,. Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo. Arthritis Rheum 2009; 60: 2747-56.
40. Pap T, Shigeyama Y, Kuchen S, Fernihough JK, Simmen B, Gay RE, et al. Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis. Arthritis Rheum 2000; 43: 1226-32.
41. Saklatvala J,. Tumour necrosis factor α stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 1986; 322: 547-9.
42. Yasukawa K, Hirano T, Watanabe Y, Muratani K, Matsuda T, Nakai S, et al. Structure and expression of human B cell stimulatory factor-2 (BSF-2/IL-6) gene. EMBO J 1987; 6: 2939-45.